Dr. Marc Shuman is Chief Medical Officer of Cellworks Group. Having dedicated over 45 years at leading academic clinical institutes across the country, Marc joined Cellworks in 2015. He uses his scientific and clinical experience to stimulate and accelerate interdisciplinary research between basic and disease-based scientists and clinical investigators.
Dr. Shuman serves on the Steering Committee for the Multiple Myeloma Translational Initiative within the Hematologic Malignancy Program in the UCSF HDF CCC, and is the Director of the Prostate Cancer Program in the Comprehensive Cancer Center at the University of California, San Francisco, CA and the Clinical Director of the California Institute for Quantitative Biomedical Research (QB3), San Francisco, CA.
Previously, he led the UCSF NCI-funded Prostate Cancer SPORE and the Proteases in Cancer Program Project grants. In addition, he was a project leader in the original Breast Cancer SPORE.